SF
PRAH

Synovus Financial’s PRA Health Sciences, Inc. PRAH Stock Holding History

Synovus Financial’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-62
Closed -$6K – 1586
2020
Q2 		$6K Sell
62
-109
-64% -$10.1K ﹤0.01% 1306
2020
Q1 		$13K Buy
171
+109
+176% +$10.6K ﹤0.01% 1506
2019
Q4 		$7K Hold
62
– – ﹤0.01% 1276
2019
Q3 		$6K Hold
62
– – ﹤0.01% 1274
2019
Q2 		$6K Hold
62
– – ﹤0.01% 1210
2019
Q1 		$7K Hold
62
– – ﹤0.01% 1184
2018
Q4 		$6K Hold
62
– – ﹤0.01% 1187
2018
Q3 		$7K Buy
+62
New +$6.46K ﹤0.01% 1197

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Synovus Financial's PRAH Position: Q3 2020 in Review

Synovus Financial sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 62 shares — an estimated $6K sold.

Synovus Financial first reported a position in PRAH in Q3 2018 and held it in 8 quarters. The position peaked at $13K in Q1 2020. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Synovus Financial reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 62 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $6K.
  • Synovus Financial first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 8 quarters.
  • Synovus Financial's PRA Health Sciences, Inc. position peaked at $13K in Q1 2020.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.